1
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Phagocytosis of Candida albicans, by concanavalin-A activated peritoneal macrophages

, , , &
Pages 195-200 | Published online: 28 Aug 2009

References

  • Klein RS, Harris CA, Small CB, et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodefi-ciency syndrome. New Engl J Med 1984; 311: 354–358.
  • Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992; 14 \((Suppl. 1)): 543–553.
  • Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia @ 1999 1SHAM, Medical Mycology, 37, 195-200 caused by Candida species and Torulo psis glabrata in the hospi-talised patients: frequency, characteristics and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11: 379–390.
  • Djeu JY, Blanchard DK. Regulation of human polymorphonu-clear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of PMN-activating factor. J Immunol 1987; 139: 2761–2767.
  • Djeu JY, Blanchard DK, Halkias D, Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol 1986; 137: 2890–2984.
  • Cenci E, Bartocci A, Pucceti P, et al. Macrophage colony-stim-ulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration. Infect Immun 1991; 59: 868–872.
  • Karbassi A, Becker JM, Foster JS, Moore RN. Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression for manno se receptors. J Immunol 1989; 139: 417-421. Blasi E, Farinelli S, Varesi L, Bistoni F. Augmentation of GG2EE macrophage cell line-mediated anti-candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Infect Immun 1990; 58: 1073–1077.
  • Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Effects of granulocyte colony-stimulating factor and interferon-gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J Leukoc Biol 1995; 57: 651–656.
  • Maródi L, Korchark HM, Johnston RB Jr. Mechanisms of host defence against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol 1991; 146: 2783–2789.
  • Felipe I, Bim S, Somensi CC. Increased clearance of Candida albicans from the peritoneal cavity of mice pre-treated with concanavalin-A or jacalin. Braz J Med Biol Res 1995; 28: 477–483.
  • Jensen J, Warner T, Balish E. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J Infect Dis 1993; 167: 912–919.
  • Qian A, Jutila MA, Rooijen NV, Cutler JE. Elimination of mouse splenic macrophages correlates with increased suscepti-bility to experimental disseminated candidiasis. J Immunol 1994; 152: 5000–5008.
  • Arraes SMAA, Gaziri LCJ, Vidotto MC, Saridakis HO, Felipe I. Pretreatment with concanavalin-A increases resistance of mice to peritoneal infection by Serratia marcescens. J Med Microbiol 1997; 46: 251–255.
  • Brummer E, Stevens DA. Candidacidal mechanisms of peri-toneal macrophages activated with lymphokines or 7-interferon. J Med Microbiol 1989; 28: 173–181.
  • Brummer E, Morrison CJ, Stevens DA. Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and non-phagocytizable fungi. Infect Immun 1985; 49: 724–730.
  • Vázquez-Torres A, Balish E. Macrophages in resistance to candidiasis. Microbiol Mol Biol Rev 1997; 61: 170–192.
  • Mar6di L, Forehand JR, Johnston RB Jr. Mechanisms of host defence against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J Immunol 1991; 146: 2790–2794.
  • Ezekowitz RAB, Willians D, Koziel H. Pneumocystis carinii uptake by alveolar macrophages is mediated via the mannose receptors. Nature 1991; 351: 155–157.
  • Ernest JD. Minireview: macrophage receptors for Mycobac-terium tuberculosis. Infect Immun 1998; 66: 1277 —1281.
  • Stahl PD. The macrophage mannose receptor: current status. Am J Resp Cell Mol Biol 1990; 2 (4): 317–319.
  • Ezekowitz RAB, Sastry K, Bailly P, Warner AA. Molecular characterisation of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like do-mains and phagocytosis of blastoconidias in Cos-1 cells. J Exp Med 1990; 172: 1785-1794.
  • Felipe I, Bim S, Loyola W. Participation of mannose receptor on the surface of stimulated macrophages in the phagocytosis of glutaraldehyde-fixed Candida albicans in vitro. Braz J Med Biol Res 1989; 22: 1251–1254.
  • Felipe I, Bochio EE, Martins NB, Pacheco C. Inhibition of macrophage phagocytosis of Escherichia coli by mannose and mannan. Braz J Med Biol Res 1991; 24: 919–924.
  • Pacheco-Soares C, Gaziri LCJ, Loyola W, Felipe I. Phagocyto-sis of enteropathogenic Escherichia coli and Candida albicans by lectin-like receptors. Braz J Med Biol Res 1992; 25: 1015–1024.
  • Kozel TR, Brown RR, Prommer GST. Activation and binding of C3 by Candida albicans. Infect Immun 1987; 55: 1890–1894.
  • Kozel TR, Weinhold LC, Lupan DM. Distinct characteristics of initiation of the classical and alternative complement path-ways by Candida albicans. Infect Immun 1996; 64: 3360–3368.
  • Morrison RP, Cutler JE. In vitro studies of the interaction of murine phagocytic cells with Candida albicans. J Reticuloen-dothel Soc 1981; 29: 23–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.